You and Me
In Curing Cancer
Accelerating together to find effective treatments for patients with rare cancer, striving for the highest quality of life
Why we need change
People in the Netherlands will get cancer
Has a rare form
New patients per year in the EU and the UK
For them, there are fewer options. And often, too late.
Research into rare cancers is expensive, biologically complex, and difficult to scale. At the same time, there’s a lack of coordination, large-scale collaboration, and interoperable infrastructure. Together, we’re changing that.
Cheaper, smarter, and faster research together
Our mission
Yamicc initiates, facilitates and coordinates large-scale collaboration to find effective treatments for cancer, with a special focus on rare cancers.
We are developing the next-generation infrastructure for clinical research – using innovative technology, including AI – and are uniting an ecosystem to make trials more affordable, smarter, and faster.
Support for clinical trials
We provide the tools needed to support clinical trials in significantly reducing both time and effort within a united data-platform.
Realization of the Yamicc Platform
Our innovative data-platform makes data FAIR (Findable, Accessible, Interoperable, Reusable), enabling large-scale data analysis.
From fragmentation to connection
Yamicc transforms today’s fragmented approach into an integrated ecosystem.
All with one shared purpose: effective treatments, faster.
Current situation:
Fragmented
When data is locked in silos,
research slows down,
or even becomes impossible.
The future:
Connection
A central, connected infrastructure accelerates clinical research and unlocks collaboration.
Partners
We are proud to collaborate with partners from healthcare, science, and the business community who help drive progress for patients with rare cancers.
Are you in?
Your support is crucial to continue our work and accelerate the path toward effective treatments and real impact for patients.
Together, we make the difference.
With your support…
- you help bring effective treatment for rare cancers within reach
- you accelerate cheaper, smarter and faster clinical research
- you directly contribute to hope for patients now, and in the future
Become a partner or major donor
Are you a company, foundation or individual looking to make a greater impact?
We’d love to explore the possibilities together.
Latest updates
-
We’re proud and excited to join forces with SUPERP to accelerate our mission!
We’re proud and excited to join forces with SUPERP to accelerate our mission! Superp’s expertise…
-
On a mission: effective treatments for rare cancer patients
On a mission: effective treatments for rare cancer patients. One year of progress. On the…
-
Yamicc Explained: Why rare cancers need a different approach
Why rare cancers need a different approach One in two people get cancer.One in five…
Edwin Cuppen
“By fully mapping the genomic profile of tumors, we can efficiently identify all potential targets for personalized, precision treatments with a single test. However, for rare cancers, there is often no registered medication available. In many patients, though, we do see promising indications for drug repurposing or experimental therapies. Yamicc fills an important missing link by efficiently designing these necessary studies and enabling experimental treatment options to actually reach patients with rare cancers.”
Edwin Cuppen
Carl Wischhoff, Recovered patient
“Connection. Between head and heart, between people and nature. The beginning of healing and a new balance. A remarkable medicine, a brilliant surgery, so much gratitude. And now Yamicc as a ‘bridge’ between all kinds of (medical) institutes. Can and may that exist? How wonderful would that be.”
Carl Wischhoff
Dr. Dannis G. van Vuurden
“As a pediatric oncologist, I know that we only make progress when we work together and share data with each other. Open and international data platforms like Yamicc are crucial to give children with brain tumors better chances. By pooling our knowledge, we accelerate the development of more effective treatments.”
Dr. Dannis G. van Vuurden
Prof. Dr. Henk Verheul
“Multidisciplinary collaboration and the use of innovative technologies like artificial intelligence on large medical databases in cancer medicine will undoubtedly contribute to better treatment outcomes for patients with cancer. I am extremely pleased that Yamicc has been established to support this type of research.”
Prof. Dr. Henk Verheul
Prof. Dr. C.M.F. (Clemens) Dirven
“Yamicc encourages research, application of experimental treatments, and data collection for patients with rare forms of cancer. This provides researchers with not only significantly more data, but also more comprehensive and higher-quality information to discover new treatments”